Lixin Science Announces GAIABONE®, the World’s First Moldable, Liquid-Resistant, and Highly Osteoinductive Synthetic Bone Graft

Under the trend of aging, the demand for bone defect repair treatment is growing, and bone grafting is the main treatment method. According to statistics from the Southern Institute, the scale of China's bone repair materials market was approximately 3.93 billion yuan in 2018, and it is expected to increase to 9.69 billion yuan by 2023.

In clinical settings, bone defects come in various shapes, requiring bone fillers to be malleable; they also need to resist fluid dispersion, meaning they can withstand the flushing of blood and water. Additionally, they are required to be biodegradable, absorbable, and capable of inducing bone regeneration.

September Corliber GAIABONE^®Corliber's regenerative artificial bone has officially obtained the Class III Medical Device Registration Certificate (Registration No. 20243131996) issued by the National Medical Products Administration (NMPA) after undergoing strict and comprehensive review. This product isThe world's first artificial bone that simultaneously meets the requirements of being repeatedly shapeable, resistant to liquid-phase collapse, and highly effective in inducing bone regeneration, filling a global market gap.

In terms of operability, Corliber GAIABONE^®Regenerative Artificial Bone is malleable like putty, can be shaped by hand at will, and provides a full filling effect. The product also meets anti-liquid dispersion requirements, ensuring stable application in aqueous surgical environments, heavy bleeding, or tissue fluid settings. GAIABONE^®With excellent osteoconductivity and osteoinductivity, bone regeneration can be completed 3-6 months after implantation.

On November 6th (Wednesday) at 18:30, VCBeat’s New Product Appreciation event is honored to inviteFounder/CEO/Chief Technology Officer of CorliberSun Yang,Corliber Co-Founder/General Manager/Medical DirectorHuang Yucheng,Corliber National Sales DirectorLiu XiaoThree guests presented the product promotion of Corliber.

It is clay-like, easy to use, and can be arbitrarily reshaped repeatedly by hand or with tools; it fills effortlessly and fully without gaps, solving the problem of difficult filling in defect areas.

Under 37° soaking and shaking conditions, it remains intact without swelling or disintegration for 90 days, and can be stably applied in endoscopic surgeries, local massive bleeding, or clinical surgical environments with excessive tissue fluid, showing no fear of any liquid-phase surgical conditions.

Outstanding bone conduction performance, utilizing HA super-dispersion technology to slowly release calcium ions and promote full contact with osteoblasts, rapidly enhancing osteogenic conversion efficiency; excellent bone induction capability completes bone regeneration within 3-6 months post-implantation, addressing localized bone regeneration issues in osteoporosis patients. Clinical experts refer to it as the "activation center."

Scan the QR code on the poster to add the assistant and schedule a live broadcast.

Sun Yang

Corliber | Founder, CEO, and Chief Technology Officer

Ph.D. in Polymer Materials from NUS, Singapore, Double Bachelor’s in Materials Science and Finance from Shanghai Jiao Tong University, Senior Engineer. Primarily responsible for the establishment of Corliber's scientific and technological platform, talent acquisition management, and financing.

Huang Yucheng

Corliber | Co-founder, General Manager, Medical Director

Bachelor of Clinical Medicine, with many years of clinical experience in tertiary hospitals and practical experience in medical devices, holding a Junior Engineer certificate and GCP (Good Clinical Practice) certification. Mainly responsible for Corliber's animal experiments, clinical trials, and product market development.

Liu Xiao

Corliber | National Sales Director

Bachelor of Clinical Medicine, Master of Science, EMBA, currently serving as the Sales Director of Corliber (Shenzhen) Medical Device Co., Ltd. Has worked for leading domestic and international orthopedic companies such as Beijing Aikang Medical and Medtronic Kanghui Orthopedics Group. With 16 years of experience in the orthopedic industry, has accumulated strong expertise in marketing, product management, customer development, project management, and the marketing of orthopedic products.

Corliber, founded by a materials science Ph.D. graduate from the National University of Singapore who returned to China, along with experts in the medical device industry and senior clinical specialists, focuses on the research and application of regenerative biomaterials, primarily used in orthopedics, dentistry, and medical aesthetics. The company utilizes its proprietary composite material technology to develop medical device products that outperform international brands, meeting clinical needs. As the only solution provider in China that achieves a fully closed-loop industrial chain for regenerative biomaterials, Corliber is committed to becoming a global leader in the regenerative medical device industry, continuously driving new product development and technological innovation.

"VCBeat New Product Review" is a live broadcast column that supports the launch of innovative medical products. The mission of the column is: to support the milestone release of every medical innovation product. If your company has plans for launching innovative medical products or major milestones and would like to participate in the VCBeat New Product Review, please contact the assistant for consultation.

Scan the QR code below to contact the assistant and schedule a live broadcast (if already added, please inquire with the assistant).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Contact the assistant to send a live broadcast screenshot, and participate in the lucky draw for a chance to win [15-day trial membership of VCBeat Industry Think Tank].